|
The Metastatic Breast Cancer Project: A national direct-to-patient initiative to accelerate genomics research. |
|
|
Stock and Other Ownership Interests - Foundation Medicine |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Siemens Healthcare Diagnostics (I) |
Consulting or Advisory Role - Siemens Healthcare Diagnostics (I) |
Research Funding - Robin Medical |
Travel, Accommodations, Expenses - Robin Medical; Siemens (I) |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Genentech/Roche; Novartis; Verastem |
Research Funding - Genentech/Roche (Inst); Novartis (Inst) |
Travel, Accommodations, Expenses - Genentech/Roche |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Foundation Medicine; H3 Biomedicine |
Consulting or Advisory Role - Foundation Medicine; H3 Biomedicine; Pfizer |